TORONTO, Ontario, Canada and BENGALURU, Karnataka, India, June 27, 2025 (GLOBE NEWSWIRE) -- Biocon Biologics Ltd. (BBL), a ...

Biotechnology firm Biocon Ltd on Thursday said its board has approved the acquisition of optionally convertible debentures of ...

The shares of Biocon, PB Fintech and GMR Airports are expected to be in focus on May 27, 2025, Friday. Biocon will acquire ...

Biocon Ltd acquires Biocon Biologics debentures from Goldman Sachs for USD 198.5 million. The acquisition involves 1,125 ...

Biotechnology firm Biocon Ltd announces its board's approval to acquire optionally convertible debentures of its subsidiary ...

S&P says Biocon will bring down adjusted debt to Rs 20,000 crore by FY26 through equity issuance, with strong cash flows ...

Siddharth Mittal, CEO & MD of Biocon says the company will evaluate Biologics IPO after committee review; current focus is on ...

With the stock currently priced at Rs 350.85, Biocon's recent financial performance, high trading volume, and presence in major market indices collectively indicate sustained investor interest and ...

Biocon Limited has made a Qualified Institutions Placement of 13,63,63,635 equity shares amounting to ₹4,500 crore. JSA ...

Biocon intends to utilise the proceeds to repay some of its outstanding debt and to purchase the outstanding optionally ...

Biocon raises ₹4,500 crore through QIP, its first equity issue since IPO, to fund innovation, repay debt, and expand global ...